Reproductive and hormonal factors and lung cancer risk in the NIH-AARP diet and health study cohort

Cancer Epidemiology Biomarkers and Prevention

Volumn 20, Issue 5, 2011, Pages 900-911

  Brinton, Louise A ^a   Gierach, Gretchen L ^a   Andaya, Abegail ^a   Park, Yikyung ^a   Schatzkin, Arthur ^a   Hollenbeck, Albert R ^b   Spitz, Margaret R ^c  

^a NATIONAL CANCER INSTITUTE   (United States)

^b AARP   (United States)

^c UNIVERSITY OF TEXAS MD ANDERSON CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ESTROGEN; HORMONE;

ADULT; AGED; ARTICLE; CANCER HORMONE THERAPY; CANCER RISK; CONFOUNDING VARIABLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESTROGEN BLOOD LEVEL; FEMALE; FOLLOW UP; HORMONAL REGULATION; HUMAN; LUNG ADENOCARCINOMA; LUNG FUNCTION; LUNG SQUAMOUS CELL CARCINOMA; MAJOR CLINICAL STUDY; MENARCHE; MENOPAUSE; OVARIECTOMY; PARITY; PRIORITY JOURNAL; REPRODUCTION; RISK ASSESSMENT; RISK REDUCTION; SELF REPORT; SMOKING;

AGED; COHORT STUDIES; DIET; FEMALE; FOLLOW-UP STUDIES; HORMONE REPLACEMENT THERAPY; HUMANS; LUNG NEOPLASMS; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; QUESTIONNAIRES; REPRODUCTIVE HISTORY; RISK FACTORS;

EID: 79955755054     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: 10.1158/1055-9965.EPI-10-1325     Document Type: Article

References (50)

1. Egleston BL, Meireles SI, Flieder DB, Clapper ML. Population-based trends in lung cancer incidence in women. Semin Oncol 2009;36:506-15.
2. Ramchandran K, Patel JD. Sex differences in susceptibility to carcinogens. Semin Oncol 2009;36:516-23.
3. Siegfried JM, Hershberger PA, Stabile LP. Estrogen receptor signaling in lung cancer. Semin Oncol 2009;36:524-31.
4. Meinhold CL, de Gonzalez AB, Bowman ED, Brenner AV, Jones RT, Lacey JV Jr, et al. Reproductive and hormonal factors and the risk of non-small cell lung cancer. Int J Cancer 2011;128:1404-13.
5. Paulus JK, Asomaning K, Kraft P, Johnson BE, Lin X, Christiani DC, et al. Parity and risk of lung cancer in women. Am J Epidemiol 2010;171:557-63.
6. Seow A, Koh WP, Wang R, Lee HP, Yu MC. Reproductive variables, soy intake, and lung cancer risk among nonsmoking women in the Singapore Chinese Health Study. Cancer Epidemiol Biomarkers Prev 2009;18:821-7.
7. Weiss JM, Lacey JV, Shu XO, Ji BT, Hou L, Yang G, et al. Menstrual and reproductive factors in association with lung cancer in female lifetime nonsmokers. Am J Epidemiol 2008;168:1319-25.
8. Kabat GC, Miller AB, Rohan TE. Reproductive and hormonal factors and risk of lung cancer in women: a prospective cohort study. Int J Cancer 2007;120:2214-20. (Pubitemid 46555861)
9. Kreuzer M, Gerken M, Heinrich J, Kreienbrock L, Wichmann HE. Hormonal factors and risk of lung cancer among women? Int J Epidemiol 2003;32:263-71.
10. Brenner AV, Wang Z, Kleinerman RA, Lei S, Metayer C, Wang W, et al. Menstrual and reproductive factors and risk of lung cancer among Chinese women, Eastern Gansu Province, 1994-1998. J Epidemiol 2003;13:22-8.
11. Koushik A, Parent ME, Siemiatycki J. Characteristics of menstruation and pregnancy and the risk of lung cancer in women. Int J Cancer 2009;125:2428-33.
12. Baik CS, Strauss GM, Speizer FE, Feskanich D. Reproductive factors, hormone use, and risk for lung cancer in postmenopausal women, the Nurses' Health Study. Cancer Epidemiol Biomarkers Prev 2010;19:2525-33.
13. Zatloukal P, Kubik A, Pauk N, Tomasek L, Petruzelka L. Adenocarcinoma of the lung among women: risk associated with smoking, prior lung disease, diet and menstrual and pregnancy history. Lung Cancer 2003;41:283-93. (Pubitemid 36970184)
14. Parker WH, Broder MS, Chang E, Feskanich D, Farquhar C, Liu Z, et al. Ovarian conservation at the time of hysterectomy and long-term health outcomes in the nurses' health study. Obstet Gynecol 2009;113:1027-37.
15. Chen KY, Hsiao CF, Chang GC, Tsai YH, Su WC, Perng RP, et al. Hormone replacement therapy and lung cancer risk in Chinese. Cancer 2007;110:1768-75.
16. Olsson H, Bladstrom A, Ingvar C. Are smoking-associated cancers prevented or postponed in women using hormone replacement therapy? Obstet Gynecol 2003;102:565-70.
17. Ramnath N, Menezes RJ, Loewen G, Dua P, Eid F, Alkhaddo J, et al. Hormone replacement therapy as a risk factor for non-small cell lung cancer: results of a case-control study. Oncology 2007;73:305-10. (Pubitemid 351862020)
18. Rodriguez C, Spencer Feigelson H, Deka A, Patel AV, Jacobs EJ, Thun MJ, et al. Postmenopausal hormone therapy and lung cancer risk in the cancer prevention study II nutrition cohort. Cancer Epidemiol Biomarkers Prev 2008;17:655-60. (Pubitemid 351469216)
19. Schabath MB, Wu X, Vassilopoulou-Sellin R, Vaporciyan AA, Spitz MR. Hormone replacement therapy and lung cancer risk: a casecontrol analysis. Clin Cancer Res 2004;10:113-23. (Pubitemid 38114169)
20. Schwartz AG, Wenzlaff AS, Prysak GM, Murphy V, Cote ML, Brooks SC, et al. Reproductive factors, hormone use, estrogen receptor expression and risk of non small-cell lung cancer in women. J Clin Oncol 2007;25:5785-92.
21. Chlebowski RT, Schwartz AG, Wakelee H, Anderson GL, Stefanick ML, Manson JE, et al. Oestrogen plus progestin and lung cancer in postmenopausal women (Women's Health Initiative trial): a posthoc analysis of a randomised controlled trial. Lancet 2009;374:1243-51.
22. Chlebowski RT, Anderson GL, Manson JE, Schwartz AG, Wakelee H, Gass M, et al. Lung cancer among postmenopausal women treated with estrogen alone in the women's health initiative randomized trial. J Natl Cancer Inst 2010;102:1413-21.
23. Schatzkin A, Subar AF, Thompson FE, Harlan LC, Tangrea J, Hollen-beck AR, et al. Design and serendipity in establishing a large cohort with wide dietary intake distributions: the National Institutes of Health-American Association of Retired Persons Diet and Health Study. Am J Epidemiol 2001;154:1119-25. (Pubitemid 33140635)
24. Michaud DS, Micthune D, Hermansen S, Leitzmann M, Harlan LC, Kipnis V, et al. Comparison of cancer registry case ascertainment with SEER estimates and self-reporting in a subset of the NIH-AARP Diet and Health Study. J Regist Manag 2005;32:70-5.
25. Fritz A, Percy C, Jack A, Shanmugaratnam K, Sobin L, Parkin DM, et al. International Classification of Diseases for Oncology, 3. Geneva, Switzerland: World Health Organization; 2000.
26. Gail NH, Lubin JH, Rubinstein LV. Likelihood calculations for matched case-control studies and survival studies with tied death times. Biometrika 1981;68:703-7.
27. Midgette AS, Baron JA. Cigarette smoking and the risk of natural menopause. Epidemiology 1990;1:474-80.
28. Seow A, Poh WT, Teh M, Eng P, Wang YT, Tan WC, et al. Diet, reproductive factors and lung cancer risk among Chinese women in Singapore: evidence for a protective effect of soy in nonsmokers. Int J Cancer 2002;97:365-71. (Pubitemid 34049029)
29. Elliott AM, Hannaford PC. Use of exogenous hormones by women and lung cancer: evidence from the Royal College of General Practitioners' Oral Contraception Study. Contraception 2006;73:331-5. (Pubitemid 43375089)
30. Gao YT, Blot WJ, Zheng W, Ershow AG, Hsu CW, Levin LI, et al. Lung cancer among Chinese women. Int J Cancer 1987;40:604-9. (Pubitemid 18003846)
31. Liu Y, Inoue M, Sobue T, Tsugane S. Reproductive factors, hormone use and the risk of lung cancer among middle-aged never-smoking Japanese women: a large-scale population-based cohort study. Int J Cancer 2005;117:662-6. (Pubitemid 41504556)
32. Wu-Williams AH, Dai XD, Blot W, Xu ZY, Sun XW, Xiao HP, et al. Lung cancer among women in north-east China. Br J Cancer 1990;62:982-7.
33. Wu AH, Yu MC, Thomas DC, Pike MC, Henderson BE. Personal and family history of lung disease as risk factors for adenocarcinoma of the lung. Cancer Res 1988;48:7279-84. (Pubitemid 19014017)
34. Kabat GC, Kim M, Hunt JR, Chlebowski RT, Rohan TE. Body mass index and waist circumference in relation to lung cancer risk in the Women's Health Initiative. Am J Epidemiol 2008;168:158-69. (Pubitemid 351951596)
35. Taioli E, Wynder EL. Re: endocrine factors and adenocarcinoma of the lung in women. J Natl Cancer Inst 1994;86:869-70.
36. Adami HO, Persson I, Hoover R, Schairer C, Bergkvist L. Risk of cancer in women receiving hormone replacement therapy. Int J Cancer 1989;44:833-9. (Pubitemid 20007980)
37. Blackman JA, Coogan PF, Rosenberg L, Strom BL, Zauber AG, Palmer JR, et al. Estrogen replacement therapy and risk of lung cancer. Pharmacoepidemiol Drug Saf 2002;11:561-7. (Pubitemid 35345406)
38. Clague J, Reynolds P, Sullivan-Halley J, Ma H, Lacey JV, Henderson KD, et al. Menopausal hormone therapy does not influence lung cancer risk: results from the California Teachers Study. Cancer Epidemiol Biomarkers Prev 2011;20:560-4.
39. Slatore CG, Chien JW, Au DH, Satia JA, White E. Lung cancer and hormone replacement therapy: association in the vitamins and lifestyle study. J Clin Oncol 2010;28:1540-6.
40. Chlebowski RT. Menopausal hormone therapy, hormone receptor status, and lung cancer in women. Semin Oncol 2009;36:566-71.
41. Freedman ND, Leitzmann MF, Hollenbeck AR, Schatzkin A, Abnet CC. Cigarette smoking and subsequent risk of lung cancer in men and women: analysis of a prospective cohort study. Lancet Oncol 2008;9:649-56.
42. Macsali F, Real FG, Plana E, Sunyer J, Anto J, Dratva J, et al. Early age of menarche, lung function and adult asthma. Am J Respir Crit Care Med 2011;183:8-14.
43. Brown DW, Young KE, Anda RF, Giles WH. Asthma and risk of death from lung cancer: NHANES II Mortality Study. J Asthma 2005;42:597-600. (Pubitemid 41765312)
44. Tanko LB, Christiansen C. An update on the antiestrogenic effect of smoking: a literature review with implications for researchers and practitioners. Menopause 2004;11:104-9. (Pubitemid 40362206)
45. Beral V, Bull D, Reeves G. Endometrial cancer and hormone-replacement therapy in the Million Women Study. Lancet 2005;365:1543-51.
46. Brinton LA, Richesson D, Leitzmann MF, Gierach GL, Schatzkin A, Mouw T, et al. Menopausal hormone therapy and breast cancer risk in the NIH-AARP Diet and Health Study Cohort. Cancer Epidemiol Biomarkers Prev 2008;17:3150-60.
47. Patel JD, Bach PB, Kris MG. Lung cancer in US women: a contemporary epidemic. JAMA 2004;291:1763-8. (Pubitemid 38489898)
48. Bird MD, Karavitis J, Kovacs EJ. Sex differences and estrogen modulation of the cellular immune response after injury. Cell Immunol 2008;252:57-67.
49. Morani A, Warner M, Gustafsson JA. Biological functions and clinical implications of oestrogen receptors alfa and beta in epithelial tissues. J Intern Med 2008;264:128-42. (Pubitemid 351962577)
50. Samet JM, Avila-Tang E, Boffetta P, Hannan LM, Olivo-Marston S, Thun MJ, et al. Lung cancer in never smokers: clinical epidemiology and environmental risk factors. Clin Cancer Res 2009;15:5626-45.